Every company working on vaccines, etc. has benefited from Operation Warp Speed. Pfizer worked hand and hand with the crash program. The mobilization is akin to the Manhattan Project.
The Newsweek headline, and New York Times quotes contained in it, is PURE FANTASY, driven by their bias, not reality.
To wit: DR. DOLSTEN: "Mr. President, Mr. Vice President, I’m chief scientist for Pfizer."
THE PRESIDENT: "Yeah."
DR. DOLSTEN: "We are very pleased to be here. And, for us, it’s been always important, when there’s a major public health threats, to come together across the industry, with biotechs and federal agencies. We are highly appreciative of the initiative that you’re taking in this powerful way to have all of us around this table.
"Pfizer, as you know, is a proud American company. We have 170 years of experience, originally founded in Brooklyn and headquartered in New York. And we have brought many vaccines, therapeutics of small or large types for patients suffering from many different diseases, including infectious diseases.
"Now, specifically for the COVID-19, the coronavirus, we have identified compounds — medicines that we have that we think (inaudile) activity against very related viruses — have good, high probability to be active against COVID-19. And, in March, we are confirming that assumption with laboratories that have access to do this (inaudible) work of using the live virus to perform activity.
"That would allow us to work closely with Dr. Hahn here at the FDA and identify the fastest path to bring it to patients. That should happen, if things go well, this year. And as soon as possible, I can hear your encouragement to all of us.
"I want also to say that Pfizer has 30 — 3-0 — R&D manufacturing sites in the U.S.; more than 30,000 Americans involved in making or discovering medicines. And we’re willing to share our experience, our capabilities as a team here, to make sure that the public in America gets the best solutions.
THE PRESIDENT: "So do you expect to be dealing with each other a little bit? You’re competitors, but in this case, it’s different. This is something we want to get done very quickly. Do you expect to be sharing your own capabilities with Pfizer and everybody else?"
PARTICIPANT: "Absolutely."
THE PRESIDENT: "Good."
DR. DOLSTEN: "I think the (inaudible) that have come from you makes all of us feel that we should be one team here."
THE PRESIDENT: "I agree. We would appreciate that."
DR. DOLSTEN: "And as a closing remark, we’ve had a tremendous partnership with NIH and NIAID in many areas being — pioneering to bring medicine or advances forward with CDC dialogues and with FDA here. So for us — we look forward to extend this relationship to make sure that Americans can, as fast as possible, given your encouragement to us, we have different options to protect them. Protection is by vaccines. To deal with those that are exposed, we need treatment, and those that are ill, we need treatment."
"So it’s not just one solution. I think, from this team, we should offer multiple approaches — therapeutic and vaccines — (inaudible)."
THE PRESIDENT: "Do you see that happening? Because I notice you have a few different variants of what we’re talking about
. Do you see that happening where maybe there are different either therapeutics or vaccines, or both, where you use combinations of each, maybe in different areas?"
DR. DOLSTEN: "I think you are right on the frontier of science; it is about
combination. And even looking at colleagues here at Gilead, we have learned that if you have two different mechanisms and put them together as treatment, the likelihood of curing, or (inaudible) responses is higher. And we actually work on complementary mechanisms."
THE PRESIDENT: "I think it’s fantastic. I love —"
MR. O’DAY: "It’s been the story of HIV."
THE PRESIDENT: "Yeah. I love the complementary. If you can do that, I love the complementary."
DR. DOLSTEN: "You can count on our commitment here."
THE PRESIDENT: "Yeah, that’s fantastic. Thank you very much. That’s, really, very exciting."
https://www.whitehouse.gov/briefings-statements/remarks-president-trump-members-coronavirus-task-force-meeting-pharmaceutical-companies/